Compositions and methods for treating CNS disorders
US12421275B2 · kind B2 · utility
0Cited by
4References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2023 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Jun 5, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J75/005
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein is a compound of Formula (I-I) or a pharmaceutically acceptable salt thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I-I), and methods of using the compounds, e.g., in the treatment of CNS-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.